Monitor next quarter for sustained TMTT growth and margin expansion, as raised guidance and strong TAVR/TMTT momentum signal continued outperformance.
Price Chart
Executive Summary
Edwards Lifesciences reported strong Q1 2026 results with sales up 16.7% to $1.65B and adjusted EPS of $0.78, beating consensus by $0.05. The company raised full-year 2026 guidance for sales growth to 9-11% (from 8-10%) and adjusted EPS to $2.95-$3.05 (from $2.90-$3.05), citing strong TAVR and TMTT momentum and clinical catalysts.
Key Financial Metrics
Key Facts
- Q1 sales grew 16.7% YoY to $1.65B, constant currency growth of 12.7%
- Q1 adjusted EPS was $0.78, beating consensus of $0.73
- Raised full-year 2026 constant currency sales growth guidance to 9-11% (from 8-10%)
- Raised full-year 2026 adjusted EPS guidance midpoint to $2.95-$3.05 (from $2.90-$3.05)
- Completed $500M accelerated share repurchase
Financial Impact
$0.05 EPS beat and raised full-year guidance
Risk Factors
- Increased guidance raises bar for future quarters
- TMTT growth may face competitive pressures
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001099800-26-000021 |
| Document: ew-20260423.htm | 0001099800-26-000021 |
| Document: 0001099800-26-000021-index-headers.html | 0001099800-26-000021 |
| Document: 0001099800-26-000021-index.html | 0001099800-26-000021 |
| Document: 0001099800-26-000021.txt | 0001099800-26-000021 |
| 8-K Data (Synthetic) | 0001099800-26-000021 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | Insider Cluster | $90.74 $86.32 | ▼ −4.87% | ▼ −5.19% | $85.54 (−5.73%) |
Aug 28, 2026 5w ago | Insider Cluster | $90.21 $86.29 | ▼ −4.35% | ▼ −4.85% | $85.54 (−5.18%) |
Aug 26, 2026 5w ago | Insider Cluster | $89.95 $85.47 | ▼ −4.99% | ▼ −4.88% | $85.54 (−4.90%) |
Aug 10, 2026 7w ago | Court Ruling | $91.94 $86.72 | ▼ −5.67% | ▼ −4.76% | $85.54 (−6.96%) |
Jul 30, 2026 9w ago | Insider Cluster | $86.07 $90.21 | ▲ +4.81% | ▲ +1.82% | $85.54 (−0.62%) |
Jul 28, 2026 9w ago | Insider Cluster | $85.76 $90.78 | ▲ +5.85% | ▲ +0.83% | $85.54 (−0.26%) |
May 29, 2026 17w ago | Insider Cluster | $88.17 $91.18 | ▲ +3.42% | ▲ +5.73% | $85.54 (−2.98%) |
May 18, 2026 19w ago | Insider Cluster | $82.11 $88.58 | ▲ +7.88% | ▲ +5.62% | $85.54 (+4.18%) |
May 18, 2026 19w ago | Insider Cluster | $82.11 $88.58 | ▲ +7.88% | ▲ +5.62% | $85.54 (+4.18%) |
May 8, 2026 20w ago | 8-K | $77.08 $87.54 | ▲ +13.57% | ▲ +13.88% | $85.54 (+10.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access